Combined sulforaphane and β-sitosterol mitigate olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways
Title:
Combined sulforaphane and β-sitosterol mitigate olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways
Author:
El-Shoura, Ehab A.M. Abdelzaher, Lobna A. Mahmoud, Nesreen I. Farghaly, Omar A. Sabry, Mostafa Girgis Shahataa, Mary Salem, Esraa A. Saad, Hebatallah M. Elhussieny, Omnya Kozman, Magy R. Atwa, Ahmed M.